Ming Zhi, Lautt W Wayne
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, 753 McDermot Avenue, Winnipeg, MB R3E 0T6, Canada.
Can J Physiol Pharmacol. 2006 Nov;84(11):1177-84. doi: 10.1139/y06-063.
Previous studies have shown that intrahepatic adenosine is involved in activation of the hepatorenal reflex that regulates renal sodium and water excretion. The present study aims to determine which subtype of adenosine receptors is implicated in the process. Mean arterial pressure, portal venous pressure and flow, and renal arterial flow were monitored in pentobarbital anesthetized rats. Urine was collected from the bladder. Intraportal administration of 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective adenosine A1 receptor antagonist, increased urine flow by 24%, 89%, and 143% at the dose of 0.01, 0.03, and 0.1 mg x kg(-1), respectively; in contrast, DPCPX, when administered intravenously at the same doses, only increased urine flow by 0%, 18%, and 36%. The increases in urine flow induced by intraportal administration of DPCPX were abolished in rats with liver denervation. Intrahepatic infusion of adenosine significantly decreased urine flow and this response was abolished by intraportal administration of DPCPX. Neither intraportal nor intravenous administration of 3,7-dimethyl-1-propargylxanthine, a selective adenosine A2 receptor antagonist, showed significant influence on urine flow. Systemic arterial pressure, renal blood flow and glomerular filtration rate were unaltered by the administration of any of the drugs. In conclusion, intrahepatic adenosine A1 receptors are responsible for the adenosine-mediated hepatorenal reflex that regulates renal water and sodium excretion.
先前的研究表明,肝内腺苷参与调节肾钠和水排泄的肝肾反射的激活。本研究旨在确定腺苷受体的哪种亚型参与了这一过程。在戊巴比妥麻醉的大鼠中监测平均动脉压、门静脉压力和流量以及肾动脉流量。从膀胱收集尿液。门静脉内注射选择性腺苷A1受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX),剂量分别为0.01、0.03和0.1mg·kg-1时,尿流量分别增加24%、89%和143%;相比之下,相同剂量静脉注射DPCPX时,尿流量仅增加0%、18%和36%。门静脉内注射DPCPX诱导的尿流量增加在去肝神经的大鼠中被消除。肝内输注腺苷显著降低尿流量,门静脉内注射DPCPX可消除此反应。选择性腺苷A2受体拮抗剂3,7-二甲基-1-丙炔基黄嘌呤门静脉内或静脉内给药均未显示对尿流量有显著影响。任何一种药物给药后,全身动脉压、肾血流量和肾小球滤过率均未改变。总之,肝内腺苷A1受体负责腺苷介导的调节肾水和钠排泄的肝肾反射。